Western Standard LLC’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-109,055	Closed	-$920K	–	32
2022 Q2	$920K	Buy	+109,055	New	+$920K	0.7%	32